相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update
Patrick F. van Rheenen et al.
JOURNAL OF CROHNS & COLITIS (2021)
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
Ruth Garcia-Romero et al.
EUROPEAN JOURNAL OF PEDIATRICS (2021)
Safety and Effectiveness of Vedolizumab for the Treatment of Pediatric Patients with Very Early Onset Inflammatory Bowel Diseases
Sylwia Fabiszewska et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease
Michael T. Dolinger et al.
INFLAMMATORY BOWEL DISEASES (2021)
Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study
Temara M. Hajjat et al.
CROHNS & COLITIS 360 (2021)
Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study
Temara M. Hajjat et al.
CROHNS & COLITIS 360 (2021)
Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary
Dan Turner et al.
GUT (2020)
Anti-tumor Necrosis Factor-alpha Exposure Impacts Vedolizumab Mucosal Healing Rates in Pediatric Inflammatory Bowel Disease
Jacqueline Jossen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study
Renata Bor et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature
Christine Olbjorn et al.
PEDIATRIC DRUGS (2020)
Effectiveness and safety of vedolizumab in biologically naive patients: A real-world multi-centre study
Fabio Salvatore Macaluso et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario
Fabiana Zingone et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center
Gabriele Dragoni et al.
JOURNAL OF DIGESTIVE DISEASES (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease
Christopher A. Lamb et al.
JOURNAL OF CROHNS & COLITIS (2018)
Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Stefan Schreiber et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition
Dan Turner et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
Paulo G. Kotze et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Anna-Maria Schneider et al.
BMC GASTROENTEROLOGY (2018)
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
Maria Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
Bruce E. Sands et al.
INFLAMMATORY BOWEL DISEASES (2017)
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Oren Ledder et al.
JOURNAL OF CROHNS & COLITIS (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
Medical management of pediatric inflammatory bowel disease
Katherine R. Baldwin et al.
SEMINARS IN PEDIATRIC SURGERY (2017)
Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease
W. A. Bye et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
Brian G. Feagan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Namita Singh et al.
INFLAMMATORY BOWEL DISEASES (2016)
A principal component analysis is conducted for a case series quality appraisal checklist
Bing Guo et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015
Charles N. Bernstein et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
Giulia Roda et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD: Evolution in the Definition and Management of Primary Nonresponse
Konstantinos Papamichael et al.
INFLAMMATORY BOWEL DISEASES (2015)
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee
Frank M. Ruemmele et al.
GUT (2015)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
New therapies for inflammatory bowel disease: from the bench to the bedside
Silvio Danese
GUT (2012)
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience
Michael B. Sprakes et al.
JOURNAL OF CROHNS & COLITIS (2012)
Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease - a population-based study
C. Jakobsen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Review article: loss of response to anti-TNF treatments in Crohn's disease
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies
Duncan Chambers et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
分享论文
